💰 America's Mayo Clinic buys into Asian lab testing: a stake in Singapore's Pathology Asia
Mayo Clinic Laboratories invested an undisclosed sum in Pathology Asia, whose labs run in six Southeast Asian countries and Australia, and in its genetic-testing unit LifeStrands Genomics.
Every funding round, exit, partnership, and corridor move in Southeast Asia — tracked daily, structured, archived. One email each evening; nothing else.
Tomorrow’s SEA deal ticker, in your inbox — every funding round, exit, and corridor move in the region, structured, daily.